Medical Nutrition Signs Retail Licensing Deal With DSE
June 11 2009 - 11:30AM
Marketwired
Medical Nutrition USA, Inc. (NASDAQ: MDNU) today announced it
signed an exclusive agreement with DSE Healthcare Solutions, LLC to
market its Proantinox� product to U.S. retail outlets.
The 10-year Trademark License Agreement gives DSE the right to
utilize intellectual property, including trademarks, patents and
formulation, relating to Proantinox�, Medical Nutrition's urinary
tract cleansing complex, in return for royalty payments based on
sales to the retail market. Medical Nutrition will continue to
market the product to the institutional market under the
UTI-Stat(TM) brand. Proantinox� (UTI- Stat(TM)) is a liquid urinary
tract cleansing complex developed by Medical Nutrition that has
been shown to be effective in reducing recurrent urinary tract
infections.
"We are pleased to partner with DSE, whose retail offerings
include Cystex�, a dual-action urinary tract analgesic that is
complementary to Proantinox� and is carried by most major food,
drug and mass market retailers. We believe that the co-marketing of
Proantinox� with the Cystex� brand will hasten its acceptance and
broaden distribution beyond what would have been achieved
independently," said Frank A. Newman, Medical Nutrition's Chairman
and Chief Executive Officer.
DSE markets leading specialty health products through a number
of national and regional retail outlets including Walgreen's, CVS,
Rite Aid, Walmart, Target stores, Duane Reade, Safeway, Winn Dixie
and Giant Foods.
"Proantinox� is a great product that is well accepted in the
institutional market and we are excited about the opportunity to
bring it to the retail market," said Moaiz Daya, DSE's Chief
Executive Officer. "We think the addition of Proantinox� to the
Cystex� line makes for a very powerful two-punch approach to
urinary tract infections."
About DSE Healthcare Solutions, LLC
DSE Healthcare Solutions, LLC offers products that provide
relief for specialty health concerns. Examples of leading specialty
health brands include: #1 ENT doctor recommended Lipo-Flavonoid for
ringing in the ears or tinnitus; Certain Dri, the #1 doctor
recommended brand for controlling excessive underarm sweating;
Cystex, the only over-the-counter urinary pain reliever available
with a dual-action formula that eases pain and burning caused by a
UTI plus contains an antibacterial to help keep the infection from
getting worse while waiting for a doctor's appointment; Albolene�
Moisturizing Cleanser, a makeup remover that easily cleanses
stubborn mascara and lipstick, yet leaves skin feeling soft, supple
and moisturized; Anti Monkey Butt Powder, specially formulated with
calamine powder to absorb excess sweat and reduce frictional skin
irritation. Additional information is available at
www.dsehealth.com.
About Medical Nutrition USA
Medical Nutrition USA develops and distributes products for the
nutritionally at risk who are under medical supervision. Its
products are used primarily in long-term care facilities,
hospitals, dialysis clinics and bariatric clinics. The Company's
product lines include Pro-Stat�, Fiber-Stat� and UTI-Stat(TM), as
well as private label products. Additional information is available
at www.mdnu.com.
This press release contains forward-looking statements that are
subject to certain risks and uncertainties. Although we believe
that the expectations reflected in any of our forward-looking
statements are reasonable, actual results could differ materially
from those projected or assumed. Risks and uncertainties that could
cause or contribute to such material difference include, but are
not limited to, general economic conditions, changes in customer
demand, changes in trends in the nursing home, renal care, health
food and bariatric surgery markets, changes in competitive pricing
for products, and the impact of our competitors' new product
introductions. Our future financial condition and results of
operations, as well as any forward-looking statements are subject
to change and inherent risk and uncertainties. Other important
factors that may cause actual results to differ materially from
those expressed in forward-looking statements is contained in the
Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year
ended January 31, 2009 as filed with the Securities and Exchange
Commission on April 24, 2009.
Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling Vice
President/CFO 800.221.0308 Email Contact Investor Relations Adam
Friedman 212.981.2529 x18 Email Contact
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Jul 2023 to Jul 2024